Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,640 | 8,570 | 2,440 | 1,940 | 690 |
| Receivables | 20,830 | 19,800 | 17,850 | 15,290 | 13,830 |
| Inventories | 560 | 340 | 700 | 560 | 300 |
| Other current assets | 1,500 | 1,510 | 5,630 | 5,750 | 3,340 |
| TOTAL | $31,530 | $30,220 | $26,620 | $23,540 | $18,160 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 12,180 | 12,440 | 7,140 | 7,200 | 7,280 |
| TOTAL | $12,180 | $12,440 | $7,140 | $7,200 | $7,280 |
| Total Assets | $48,920 | $47,010 | $37,070 | $36,250 | $31,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,000 | 3,550 | 2,440 | 2,300 | 2,570 |
| Accrued Expenses | 620 | 1,050 | 1,000 | 910 | 560 |
| Other current liabilities | 0 | 0 | 100 | 2,700 | 2,550 |
| TOTAL | $5,550 | $6,090 | $4,540 | $7,280 | $6,170 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,550 | $6,090 | $4,540 | $7,280 | $6,170 |
| Shareholders' Equity | |||||
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | 22,670 | 20,410 | 21,390 | 18,260 | 14,410 |
| Other shareholders' equity | 690 | 690 | 690 | 250 | 250 |
| TOTAL | $43,370 | $40,920 | $32,530 | $28,960 | $25,110 |
| Total Liabilities And Equity | $48,920 | $47,010 | $37,070 | $36,240 | $31,280 |